{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:56:29Z","timestamp":1791932189541,"version":"4.3.4"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T00:00:00Z","timestamp":1783209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":92,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100021077","name":"Vice Chancellor for Research and Technology, Kerman University of Medical Sciences","doi-asserted-by":"publisher","award":["IR.KMU.AH.REC.1402.009"],"award-info":[{"award-number":["IR.KMU.AH.REC.1402.009"]}],"id":[{"id":"10.13039\/501100021077","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-60753-x","type":"journal-article","created":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T19:23:16Z","timestamp":1783279396000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["BSA-curcumin nanoparticles selectively target breast cancer cells and reprogram the immunosuppressive tumor microenvironment in vitro"],"prefix":"10.1038","volume":"16","author":[{"given":"Saad","family":"Asakere","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Mohammad","family":"Zahedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajjad","family":"Heydari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Matloubi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Nosratabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roohollah Mirzaee","family":"Khalilabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4204-8769","authenticated-orcid":false,"given":"Ladan","family":"Langroudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,5]]},"reference":[{"issue":"3","key":"60753_CR1","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s00262-021-03013-3","volume":"71","author":"N Behranvand","year":"2022","unstructured":"Behranvand, N. et al. Chemotherapy: a double-edged sword in cancer treatment. Cancer Immunol. Immunother. 71 (3), 507\u2013526 (2022). 20210805th ed.","journal-title":"Cancer Immunol. Immunother"},{"key":"60753_CR2","doi-asserted-by":"crossref","unstructured":"Rudzi\u0144ska, A. et al. Phytochemicals in Cancer Treatment and Cancer Prevention-Review on Epidemiological Data and Clinical Trials. Nutrients. 20230414th ed. 15(8). (2023).","DOI":"10.3390\/nu15081896"},{"key":"60753_CR3","doi-asserted-by":"publisher","first-page":"100113","DOI":"10.1016\/j.arres.2024.100113","volume":"13","author":"JK Paul","year":"2024","unstructured":"Paul, J. K. et al. Phytochemical-mediated modulation of signaling pathways: A promising avenue for drug discovery. Adv. Redox Res. 13, 100113 Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2667137924000201 (2024).","journal-title":"Adv. Redox Res."},{"issue":"5","key":"60753_CR4","doi-asserted-by":"publisher","first-page":"5728","DOI":"10.1002\/jcp.27442","volume":"234","author":"B Farhood","year":"2019","unstructured":"Farhood, B. et al. Curcumin as an anti-inflammatory agent: Implications to radiotherapy and chemotherapy. J. Cell. Physiol. 234 (5), 5728\u20135740 (2019). 20181014th ed.","journal-title":"J. Cell. Physiol."},{"key":"60753_CR5","doi-asserted-by":"publisher","unstructured":"Cacciola, N. A. et al. An Overview of the Enhanced Effects of Curcumin and Chemotherapeutic Agents in Combined Cancer Treatments. Int. J. Mol. Sci. 24(16), 12587. (2023). https:\/\/doi.org\/10.3390\/ijms241612587","DOI":"10.3390\/ijms241612587"},{"key":"60753_CR6","doi-asserted-by":"publisher","first-page":"133180","DOI":"10.1016\/j.molstruc.2022.133180","volume":"1263","author":"P Li","year":"2022","unstructured":"Li, P. et al. Curcumin selectively induces colon cancer cell apoptosis and S cell cycle arrest by regulates Rb\/E2F\/p53 pathway. J. Mol. Struct. 1263, 133180 Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0022286022008377 (2022).","journal-title":"J. Mol. Struct."},{"issue":"2","key":"60753_CR7","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/bab.1836","volume":"67","author":"H Bashang","year":"2020","unstructured":"Bashang, H. & Tamma, S. The use of curcumin as an effective adjuvant to cancer therapy: A short review. Biotechnol. Appl. Biochem. 67 (2), 171\u2013179 (2020). 20191103rd ed.","journal-title":"Biotechnol. Appl. Biochem."},{"key":"60753_CR8","doi-asserted-by":"publisher","unstructured":"Gallien, J. et al. Curcumin Loaded Dendrimers Specifically Reduce Viability of Glioblastoma Cell Lines. Molecules 20211006th ed. 26(19), 6050 (2021). https:\/\/doi.org\/10.3390\/molecules26196050","DOI":"10.3390\/molecules26196050"},{"issue":"10","key":"60753_CR9","doi-asserted-by":"publisher","first-page":"6447","DOI":"10.1039\/C9FO01338E","volume":"10","author":"M Huang","year":"2019","unstructured":"Huang, M. et al. Liposome co-encapsulation as a strategy for the delivery of curcumin and resveratrol. Food Funct. 10 (10), 6447\u20136458 (2019).","journal-title":"Food Funct."},{"key":"60753_CR10","doi-asserted-by":"publisher","first-page":"119340","DOI":"10.1016\/j.ijpharm.2020.119340","volume":"583","author":"A Gupta","year":"2020","unstructured":"Gupta, A. et al. Formulation and characterization of curcumin loaded polymeric micelles produced via continuous processing. Int. J. Pharm. 583, 119340 Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0378517320303240 (2020).","journal-title":"Int. J. Pharm."},{"key":"60753_CR11","doi-asserted-by":"publisher","first-page":"119875","DOI":"10.1016\/j.ijpharm.2020.119875","volume":"589","author":"K Xiong","year":"2020","unstructured":"Xiong, K. et al. Co-delivery of paclitaxel and curcumin by biodegradable polymeric nanoparticles for breast cancer chemotherapy. Int. J. Pharm. 589, 119875 (2020). 20200909th ed.","journal-title":"Int. J. Pharm."},{"issue":"5","key":"60753_CR12","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1021\/acs.molpharmaceut.1c00046","volume":"18","author":"A Spada","year":"2021","unstructured":"Spada, A., Emami, J., Tuszynski, J. A. & Lavasanifar, A. The Uniqueness of Albumin as a Carrier in Nanodrug Delivery. Mol. Pharm. 18 (5), 1862\u20131894 (2021). 20210331st ed.","journal-title":"Mol. Pharm."},{"key":"60753_CR13","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jconrel.2016.12.040","volume":"263","author":"J Park","year":"2017","unstructured":"Park, J., Sun, B. & Yeo, Y. Albumin-coated nanocrystals for carrier-free delivery of paclitaxel. J. Control Release. 263, 90\u2013101 (2017). 20161231st ed.","journal-title":"J. Control Release"},{"key":"60753_CR14","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ijbiomac.2020.04.130","volume":"159","author":"Z Hasanpoor","year":"2020","unstructured":"Hasanpoor, Z., Mostafaie, A., Nikokar, I. & Hassan, Z. M. Curcumin-human serum albumin nanoparticles decorated with PDL1 binding peptide for targeting PDL1-expressing breast cancer cells. Int. J. Biol. Macromol. 159, 137\u2013153 (2020). 20200423rd ed.","journal-title":"Int. J. Biol. Macromol."},{"key":"60753_CR15","doi-asserted-by":"publisher","unstructured":"Wu, J. The Enhanced Permeability and Retention (EPR) Effect: The Significance of the Concept and Methods to Enhance Its Application. J. Pers. Med. 11(8), 771 (2021). https:\/\/doi.org\/10.3390\/jpm11080771","DOI":"10.3390\/jpm11080771"},{"issue":"9","key":"60753_CR16","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/nm1093","volume":"10","author":"TJ Curiel","year":"2004","unstructured":"Curiel, T. J. et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat. Med. 10 (9), 942\u2013949 (2004). 20040822nd ed.","journal-title":"Nat. Med."},{"issue":"10","key":"60753_CR17","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1111\/cas.15068","volume":"112","author":"H Nakamura","year":"2021","unstructured":"Nakamura, H. & Takada, K. Reactive oxygen species in cancer: Current findings and future directions. Cancer Sci. 112 (10), 3945\u20133952 (2021). 20210802nd ed.","journal-title":"Cancer Sci."},{"issue":"4","key":"60753_CR18","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/ni1178","volume":"6","author":"S Sakaguchi","year":"2005","unstructured":"Sakaguchi, S. Naturally arising Foxp3-expressing CD25\u2009+\u2009CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6 (4), 345\u2013352 (2005).","journal-title":"Nat. Immunol."},{"key":"60753_CR19","unstructured":"Langroudi, L., Hassan, Z. M., Soleimani, M. & Hashemi, S. M. Tumor associated mesenchymal stromal cells show higher immunosuppressive and angiogenic properties compared to adipose derived MSCS. Iran. J. Immunol. 12(4), 226\u201339. (2015)."},{"issue":"1","key":"60753_CR20","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s40199-020-00331-2","volume":"28","author":"Z Matloubi","year":"2020","unstructured":"Matloubi, Z. & Hassan, Z. HSA-curcumin nanoparticles: a promising substitution for Curcumin as a Cancer chemoprevention and therapy. Daru 28 (1), 209\u2013219 (2020). 20200408th ed.","journal-title":"Daru"},{"issue":"1","key":"60753_CR21","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0378-5173(99)00370-1","volume":"194","author":"C Weber","year":"2000","unstructured":"Weber, C., Coester, C., Kreuter, J. & Langer, K. Desolvation process and surface characterisation of protein nanoparticles. Int. J. Pharm. 194 (1), 91\u2013102 (2000).","journal-title":"Int. J. Pharm."},{"issue":"7","key":"60753_CR22","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods. 9 (7), 671\u2013675 (2012).","journal-title":"Nat. Methods"},{"key":"60753_CR23","unstructured":"Bugdayci, G. & Kaymakci, M. Nitrite\/nitrate and malondialdehyde levels in nasal polyp. Cell Mol Biol (Noisy-le-grand). 20081028th ed. 54 (Suppl:Ol)1043-5. (2008)."},{"issue":"4","key":"60753_CR24","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1128\/CVI.00161-07","volume":"15","author":"C Nilsson","year":"2008","unstructured":"Nilsson, C. et al. Optimal blood mononuclear cell isolation procedures for gamma interferon enzyme-linked immunospot testing of healthy Swedish and Tanzanian subjects. Clin. Vaccine Immunol. 15 (4), 585\u2013589 (2008). 20080220th ed.","journal-title":"Clin. Vaccine Immunol."},{"issue":"8","key":"60753_CR25","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.1021\/acs.biomac.3c00363","volume":"24","author":"E Argitekin","year":"2023","unstructured":"Argitekin, E., Ersoz-Gulseven, E., Cakan-Akdogan, G. & Akdogan, Y. Dopamine-Conjugated Bovine Serum Albumin Nanoparticles Containing pH-Responsive Catechol-V(III) Coordination for In Vitro and. Vivo Drug Delivery Biomacromolecules. 24 (8), 3603\u20133618. Available from: https:\/\/doi.org\/10.1021\/acs.biomac.3c00363 (2023).","journal-title":"Vivo Drug Delivery Biomacromolecules"},{"issue":"1","key":"60753_CR26","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jconrel.2011.09.069","volume":"157","author":"B Elsadek","year":"2012","unstructured":"Elsadek, B. & Kratz, F. Impact of albumin on drug delivery\u2013new applications on the horizon. J. Control Release. 157 (1), 4\u201328 (2012). 20110916th ed.","journal-title":"J. Control Release"},{"key":"60753_CR27","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.apsusc.2014.08.170","volume":"334","author":"SS Rohiwal","year":"2015","unstructured":"Rohiwal, S. S. et al. Investigating the influence of effective parameters on molecular characteristics of bovine serum albumin nanoparticles. Appl. Surf. Sci. 334, 157\u2013164 Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0169433214019485 (2015).","journal-title":"Appl. Surf. Sci."},{"issue":"3","key":"60753_CR28","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jconrel.2008.05.010","volume":"132","author":"F Kratz","year":"2008","unstructured":"Kratz, F. Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. J. Control Release. 132 (3), 171\u2013183 (2008). 20080517th ed.","journal-title":"J. Control Release"},{"key":"60753_CR29","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.colsurfa.2014.03.011","volume":"450","author":"MW Ahmad","year":"2014","unstructured":"Ahmad, M. W. et al. Bovine serum albumin (BSA) and cleaved-BSA conjugated ultrasmall Gd2O3 nanoparticles: Synthesis, characterization, and application to MRI contrast agents. Colloids Surf. Physicochem Eng. Asp. 450, 67\u201375 Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0927775714002337 (2014).","journal-title":"Colloids Surf. Physicochem Eng. Asp"},{"issue":"5","key":"60753_CR30","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1080\/02652048.2018.1526340","volume":"35","author":"LEA Camargo","year":"2018","unstructured":"Camargo, L. E. A. et al. Bovine serum albumin nanoparticles improve the antitumour activity of curcumin in a murine melanoma model. J. Microencapsul. 35 (5), 467\u2013474 (2018). 20181130th ed.","journal-title":"J. Microencapsul."},{"key":"60753_CR31","doi-asserted-by":"publisher","first-page":"135761","DOI":"10.1016\/j.molstruc.2023.135761","volume":"1287","author":"L Tyukodi","year":"2023","unstructured":"Tyukodi, L. et al. Serum albumin binding studies on antiproliferative cyclic C5-curcuminoid derivatives using spectroscopic methods and molecular modelling. J. Mol. Struct. 1287, 135761 Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0022286023008578 (2023).","journal-title":"J. Mol. Struct."},{"key":"60753_CR32","first-page":"5475","volume":"10","author":"J Li","year":"2015","unstructured":"Li, J. et al. Synthesis, characterization, and in vitro evaluation of curcumin-loaded albumin nanoparticles surface-functionalized with glycyrrhetinic acid. Int. J. Nanomed. 10, 5475\u20135487 (2015). 20150827th ed.","journal-title":"Int. J. Nanomed."},{"key":"60753_CR33","doi-asserted-by":"crossref","unstructured":"Huang, Y. et al. Curcumin-loaded galactosylated BSA nanoparticles as targeted drug delivery carriers inhibit hepatocellular carcinoma cell proliferation and migration. Int. J. Nanomed. 8309\u20138323. (2018).","DOI":"10.2147\/IJN.S184379"},{"issue":"2","key":"60753_CR34","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1208\/s12249-018-1279-6","volume":"20","author":"RS Nair","year":"2019","unstructured":"Nair, R. S., Morris, A., Billa, N. & Leong, C. O. An Evaluation of Curcumin-Encapsulated Chitosan Nanoparticles for Transdermal Delivery. AAPS PharmSciTech. 20190110th ed. 20 (2), 69 (2019).","journal-title":"AAPS PharmSciTech"},{"issue":"1\u20132","key":"60753_CR35","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ijpharm.2012.01.003","volume":"425","author":"KL Nair","year":"2012","unstructured":"Nair, K. L., Thulasidasan, A. K., Deepa, G., Anto, R. J. & Kumar, G. S. Purely aqueous PLGA nanoparticulate formulations of curcumin exhibit enhanced anticancer activity with dependence on the combination of the carrier. Int. J. Pharm. 425 (1\u20132), 44\u201352 (2012). 20120113th ed.","journal-title":"Int. J. Pharm."},{"issue":"1","key":"60753_CR36","doi-asserted-by":"publisher","first-page":"e08674","DOI":"10.1016\/j.heliyon.2021.e08674","volume":"8","author":"Y Herdiana","year":"2022","unstructured":"Herdiana, Y., Wathoni, N., Shamsuddin, S. & Muchtaridi, M. Drug release study of the chitosan-based nanoparticles. Heliyon 8 (1), e08674 Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2405844021027778 (2022).","journal-title":"Heliyon"},{"issue":"1\u20132","key":"60753_CR37","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.ijpharm.2010.10.041","volume":"403","author":"TH Kim","year":"2011","unstructured":"Kim, T. H. et al. Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity. Int. J. Pharm. 403 (1\u20132), 285\u2013291 (2011). 20101028th ed.","journal-title":"Int. J. Pharm."},{"key":"60753_CR38","doi-asserted-by":"publisher","first-page":"101692","DOI":"10.1016\/j.mtcomm.2020.101692","volume":"25","author":"R Augustine","year":"2020","unstructured":"Augustine, R. et al. Cellular uptake and retention of nanoparticles: Insights on particle properties and interaction with cellular components. Mater Today Commun. 25, 101692. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2352492820327033 (2020).","journal-title":"Mater Today Commun"},{"key":"60753_CR39","doi-asserted-by":"publisher","first-page":"1329636","DOI":"10.3389\/fphar.2024.1329636","volume":"15","author":"Q Ji","year":"2024","unstructured":"Ji, Q. et al. GP60 and SPARC as albumin receptors: key targeted sites for the delivery of antitumor drugs. Front. Pharmacol. 15, 1329636 (2024). 20240123rd ed.","journal-title":"Front. Pharmacol."},{"key":"60753_CR40","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12935-017-0400-3","volume":"17","author":"NM Ali","year":"2017","unstructured":"Ali, N. M. et al. Synthetic curcumin derivative DK1 possessed G2\/M arrest and induced apoptosis through accumulation of intracellular ROS in MCF-7 breast cancer cells. Cancer Cell. Int. 17, 30 (2017). 20170221st ed.","journal-title":"Cancer Cell. Int."},{"issue":"5","key":"60753_CR41","first-page":"3293","volume":"25","author":"C Ramachandran","year":"2005","unstructured":"Ramachandran, C. et al. Expression profiles of apoptotic genes induced by curcumin in human breast cancer and mammary epithelial cell lines. Anticancer Res. 25 (5), 3293\u20133302 (2005).","journal-title":"Anticancer Res."},{"key":"60753_CR42","doi-asserted-by":"publisher","unstructured":"Anas, M. et al. Therapeutic potential and agricultural benefits of curcumin: a comprehensive review of health and sustainability applications. Journal of Umm Al-Qura University for Applied Sciences [Internet]. Available from: https:\/\/doi.org\/10.1007\/s43994-024-00200-7 (2024).","DOI":"10.1007\/s43994-024-00200-7"},{"key":"60753_CR43","doi-asserted-by":"publisher","unstructured":"Aggarwal, B. B., Sundaram, C., Malani, N. & Ichikawa, H. Curcumin: the Indian solid gold. In: Aggarwal, B.B., Surh, YJ., Shishodia, S. (eds) The molecular targets and therapeutic uses of curcumin in health and disease. Advances in Experimental Medicine and Biology, vol 595. Springer, Boston, MA. (2007). https:\/\/doi.org\/10.1007\/978-0-387-46401-5_1","DOI":"10.1007\/978-0-387-46401-5_1"},{"issue":"1\/A","key":"60753_CR44","first-page":"363","volume":"23","author":"BB Aggarwal","year":"2003","unstructured":"Aggarwal, B. B., Kumar, A. & Bharti, A. C. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. 23 (1\/A), 363\u2013398 (2003).","journal-title":"Anticancer Res."},{"key":"60753_CR45","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jconrel.2016.06.017","volume":"235","author":"S Bhattacharjee","year":"2016","unstructured":"Bhattacharjee, S. DLS and zeta potential - What they are and what they are not? J. Control Release. 235, 337\u2013351 (2016). 20160610th ed.","journal-title":"J. Control Release"},{"issue":"6","key":"60753_CR46","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.3892\/ol.2012.928","volume":"4","author":"JIE Zheng","year":"2012","unstructured":"Zheng, J. I. E. Energy metabolism of cancer: Glycolysis versus oxidative phosphorylation. Oncol. Lett. 4 (6), 1151\u20131157 (2012).","journal-title":"Oncol. Lett."},{"issue":"5","key":"60753_CR47","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.cell.2008.08.021","volume":"134","author":"PP Hsu","year":"2008","unstructured":"Hsu, P. P. & Sabatini, D. M. Cancer cell metabolism: Warburg and beyond. Cell 134 (5), 703\u2013707 (2008).","journal-title":"Cell"},{"issue":"6","key":"60753_CR48","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.ccr.2008.05.005","volume":"13","author":"G Kroemer","year":"2008","unstructured":"Kroemer, G. & Pouyssegur, J. Tumor cell metabolism: cancer\u2019s Achilles\u2019 heel. Cancer Cell. 13 (6), 472\u2013482 (2008).","journal-title":"Cancer Cell."},{"key":"60753_CR49","first-page":"14551","volume":"58","author":"H Gopinath","year":"2013","unstructured":"Gopinath, H., Venugopal, K., Shanmugasundaram, S. & Shanmugam, D. Anti-cancer nanoparticulate drug delivery system using biodegradable polymers. Elixir Appl. Chem. 58, 14551\u201314556 (2013).","journal-title":"Elixir Appl. Chem."},{"key":"60753_CR50","doi-asserted-by":"publisher","first-page":"106591","DOI":"10.1016\/j.ejps.2023.106591","volume":"191","author":"D Kurimoto","year":"2023","unstructured":"Kurimoto, D. & Sato, A. Enhanced intracellular uptake of an albumin fusion protein in cancer cells by its forced cell surface recruitment. Eur. J. Pharm. Sci. 191, 106591 Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S092809872300221X (2023).","journal-title":"Eur. J. Pharm. Sci."},{"key":"60753_CR51","doi-asserted-by":"publisher","unstructured":"Cho, H., Jeon, S. I., Ahn, C. H., Shim, M. K. & Kim, K. Emerging Albumin-Binding Anticancer Drugs for Tumor-Targeted Drug Delivery: Current Understandings and Clinical Translation. Pharmaceutics 20220328th ed. 14(4), 728 (2022). https:\/\/doi.org\/10.3390\/pharmaceutics14040728","DOI":"10.3390\/pharmaceutics14040728"},{"issue":"14","key":"60753_CR52","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.3390\/cancers16142580","volume":"16","author":"A Amaroli","year":"2024","unstructured":"Amaroli, A. et al. The Bright Side of Curcumin: A Narrative Review of Its Therapeutic Potential in Cancer Management. Cancers (Basel). 16 (14), 2580 Available from: https:\/\/www.mdpi.com\/2072-6694\/16\/14\/2580 (2024).","journal-title":"Cancers (Basel)"},{"issue":"1","key":"60753_CR53","first-page":"1","volume":"6","author":"AK Dutta","year":"2013","unstructured":"Dutta, A. K. & Ikiki, E. Novel drug delivery systems to improve bioavailability of curcumin. J. Bioequiv Availab. 6 (1), 1\u20139 (2013).","journal-title":"J. Bioequiv Availab."},{"issue":"3\/4","key":"60753_CR54","first-page":"91","volume":"23","author":"SP Mitra","year":"2007","unstructured":"Mitra, S. P. Binding and stability of curcumin in presence of bovine serum albumin. J. Surf. Sci. Technol. 23 (3\/4), 91 (2007).","journal-title":"J. Surf. Sci. Technol."},{"issue":"9","key":"60753_CR55","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.3390\/molecules27092758","volume":"27","author":"AM Araya-Sibaja","year":"2022","unstructured":"Araya-Sibaja, A. M. et al. Bovine serum albumin-based nanoparticles: preparation, characterization, and antioxidant activity enhancement of three main curcuminoids from curcuma longa. Molecules. 27(9), 2758. Available from: https:\/\/www.mdpi.com\/1420-3049\/27\/9\/2758 (2022).","journal-title":"Molecules"},{"issue":"4","key":"60753_CR56","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1242\/jcs.195297","volume":"130","author":"KA White","year":"2017","unstructured":"White, K. A., Grillo-Hill, B. K. & Barber, D. L. Cancer cell behaviors mediated by dysregulated pH dynamics at a glance. J. Cell. Sci. 130 (4), 663\u2013669 (2017).","journal-title":"J. Cell. Sci."},{"issue":"2","key":"60753_CR57","doi-asserted-by":"publisher","first-page":"71","DOI":"10.37349\/etat.2020.00005","volume":"1","author":"C Ward","year":"2020","unstructured":"Ward, C. et al. The impact of tumour pH on cancer progression: strategies for clinical intervention. Explor. Target. Antitumor Ther. 20200428th ed. ;1 (2), 71\u2013100 (2020).","journal-title":"Explor. Target. Antitumor Ther."},{"issue":"Suppl 1","key":"60753_CR58","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41430-020-0684-6","volume":"74","author":"T Koltai","year":"2020","unstructured":"Koltai, T. The Ph paradigm in cancer. Eur. J. Clin. Nutr. 74 (Suppl 1), 14\u201319 (2020).","journal-title":"Eur. J. Clin. Nutr."},{"issue":"1","key":"60753_CR59","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3390\/biom15010035","volume":"15","author":"A Shoari","year":"2025","unstructured":"Shoari, A., Ashja Ardalan, A., Dimesa, A. M. & Coban, M. A. Targeting Invasion: The Role of MMP-2 and MMP-9 Inhibition in Colorectal Cancer Therapy. Biomolecules. 15(1), 35. Available from: https:\/\/www.mdpi.com\/2218-273X\/15\/1\/35 (2025).","journal-title":"Biomolecules"},{"key":"60753_CR60","doi-asserted-by":"publisher","unstructured":"Hafez Ghoran, S. et al. Curcumin-Based Nanoformulations: A Promising Adjuvant towards Cancer Treatment. Molecules. 27(16), 5236 (2022). https:\/\/doi.org\/10.3390\/molecules27165236","DOI":"10.3390\/molecules27165236"},{"key":"60753_CR61","doi-asserted-by":"publisher","first-page":"216332","DOI":"10.1016\/j.canlet.2023.216332","volume":"570","author":"W Wang","year":"2023","unstructured":"Wang, W., Li, M., Wang, L., Chen, L. & Goh, B. C. Curcumin in cancer therapy: Exploring molecular mechanisms and overcoming clinical challenges. Cancer Lett. 570, 216332 Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0304383523002835 (2023).","journal-title":"Cancer Lett."},{"key":"60753_CR62","doi-asserted-by":"crossref","unstructured":"Jakubczyk, K., Dru\u017cga, A., Katarzyna, J. & Skonieczna-\u017bydecka, K. Antioxidant Potential of Curcumin-A Meta-Analysis of Randomized Clinical Trials. Antioxidants (Basel). 20201106th ed. 9(11). (2020).","DOI":"10.3390\/antiox9111092"},{"key":"60753_CR63","doi-asserted-by":"publisher","first-page":"156144","DOI":"10.1016\/j.cyto.2023.156144","volume":"164","author":"MJ Dehzad","year":"2023","unstructured":"Dehzad, M. J., Ghalandari, H., Nouri, M. & Askarpour, M. Antioxidant and anti-inflammatory effects of curcumin\/turmeric supplementation in adults: A GRADE-assessed systematic review and dose\u2013response meta-analysis of randomized controlled trials. Cytokine 164, 156144 Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1043466623000224 (2023).","journal-title":"Cytokine"},{"issue":"4","key":"60753_CR64","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1051\/bmdcn\/2019090423","volume":"9","author":"M Alizadeh","year":"2019","unstructured":"Alizadeh, M. & Kheirouri, S. Curcumin reduces malondialdehyde and improves antioxidants in humans with diseased conditions: a comprehensive meta-analysis of randomized controlled trials. Biomed. (Taipei). 20191114th ed. 9 (4), 23 (2019).","journal-title":"Biomed. (Taipei)"},{"issue":"4","key":"60753_CR65","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.3390\/ijms24043323","volume":"24","author":"Y Zeng","year":"2023","unstructured":"Zeng, Y. et al. Therapeutic Effect of Curcumin on Metabolic Diseases: Evidence from Clinical Studies. Int. J. Mol. Sci. 24 (4), 3323 Available from: https:\/\/www.mdpi.com\/1422-0067\/24\/4\/3323 (2023).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"60753_CR66","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.redox.2012.10.001","volume":"1","author":"E Kansanen","year":"2013","unstructured":"Kansanen, E., Kuosmanen, S. M., Leinonen, H. & Levonen, A. L. The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer. Redox Biol. 20130118th ed. 1 (1), 45\u201349 (2013).","journal-title":"Redox Biol."},{"issue":"5","key":"60753_CR67","doi-asserted-by":"publisher","first-page":"94","DOI":"10.4239\/wjd.v3.i5.94","volume":"3","author":"HJ He","year":"2012","unstructured":"He, H. J. et al. Curcumin attenuates Nrf2 signaling defect, oxidative stress in muscle and glucose intolerance in high fat diet-fed mice. World J. Diabetes. 3 (5), 94\u2013104 (2012).","journal-title":"World J. Diabetes"},{"issue":"6","key":"60753_CR68","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1159\/000374036","volume":"35","author":"L Shi","year":"2015","unstructured":"Shi, L. et al. MiR-141 Activates Nrf2-Dependent Antioxidant Pathway via Down-Regulating the Expression of Keap1 Conferring the Resistance of Hepatocellular Carcinoma Cells to 5-Fluorouracil. Cell. Physiol. Biochem. 35 (6), 2333\u20132348 (2015). 20150415th ed.","journal-title":"Cell. Physiol. Biochem."},{"issue":"1","key":"60753_CR69","first-page":"103","volume":"17","author":"Z Xie","year":"2018","unstructured":"Xie, Z., Wu, B., Shen, G., Li, X. & Wu, Q. Curcumin alleviates liver oxidative stress in type 1 diabetic rats. Mol. Med. Rep. 17 (1), 103\u2013108 (2018). 20171026th ed.","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"60753_CR70","doi-asserted-by":"publisher","first-page":"10499","DOI":"10.1038\/s41598-024-61278-x","volume":"14","author":"R Radha","year":"2024","unstructured":"Radha, R. et al. Enhancing Curcumin\u2019s therapeutic potential in cancer treatment through ultrasound mediated liposomal delivery. Sci. Rep. 14 (1), 10499. Available from: https:\/\/doi.org\/10.1038\/s41598-024-61278-x (2024).","journal-title":"Sci. Rep."},{"issue":"1","key":"60753_CR71","first-page":"23","volume":"19","author":"X Song","year":"2019","unstructured":"Song, X., Zhang, M., Dai, E. & Luo, Y. Molecular targets of curcumin in breast cancer (Review). Mol. Med. Rep. 19 (1), 23\u201329 (2019). 20181119th ed.","journal-title":"Mol. Med. Rep."},{"issue":"20","key":"60753_CR72","doi-asserted-by":"publisher","first-page":"20059","DOI":"10.1074\/jbc.M410670200","volume":"280","author":"T Choudhuri","year":"2005","unstructured":"Choudhuri, T., Pal, S., Das, T. & Sa, G. Curcumin selectively induces apoptosis in deregulated cyclin D1-expressed cells at G2 phase of cell cycle in a p53-dependent manner. J. Biol. Chem. 280 (20), 20059\u201320068 (2005).","journal-title":"J. Biol. Chem."},{"key":"60753_CR73","first-page":"648","volume":"4","author":"D Xu","year":"2023","unstructured":"Xu, D. et al. Curcumin nano-prodrug induces multi-phase cell cycle arrest in colorectal cancer through suppression of CDKs and specific down-regulation of PLK1. Smart Mater. Med. 4, 648\u2013660 Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2590183423000182 (2023).","journal-title":"Smart Mater. Med."},{"issue":"1","key":"60753_CR74","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1747-1028-3-14","volume":"3","author":"G Sa","year":"2008","unstructured":"Sa, G. & Das, T. Anti cancer effects of curcumin: cycle of life and death. Cell. Div. 3 (1), 14. https:\/\/doi.org\/10.1186\/1747-1028-3-14 (2008).","journal-title":"Cell. Div."},{"issue":"8","key":"60753_CR75","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3390\/nano14080672","volume":"14","author":"S Jacob","year":"2024","unstructured":"Jacob, S. et al. Advances in Nanocarrier Systems for Overcoming Formulation Challenges of Curcumin: Current Insights. Nanomaterials 14 (8), 672 Available from: https:\/\/www.mdpi.com\/2079-4991\/14\/8\/672 (2024).","journal-title":"Nanomaterials"},{"issue":"1","key":"60753_CR76","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3390\/ijms25010232","volume":"25","author":"C Focaccetti","year":"2024","unstructured":"Focaccetti, C. et al. The Combination of Bioavailable Concentrations of Curcumin and Resveratrol Shapes Immune Responses While Retaining the Ability to Reduce Cancer Cell Survival. Int J Mol Sci. 25(1), 232. Available from: https:\/\/www.mdpi.com\/1422-0067\/25\/1\/232 (2024).","journal-title":"Int J Mol Sci"},{"issue":"4","key":"60753_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/or.2021.7962","volume":"45","author":"H Zhou","year":"2021","unstructured":"Zhou, H., Ning, Y., Zeng, G., Zhou, C. & Ding, X. Curcumin promotes cell cycle arrest and apoptosis of acute myeloid leukemia cells by inactivating AKT. Oncol. Rep. 45 (4), 1 (2021).","journal-title":"Oncol. Rep."},{"issue":"2","key":"60753_CR78","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3892\/ol.2023.14200","volume":"27","author":"Y Hu","year":"2024","unstructured":"Hu, Y., Cheng, L., Du, S., Wang, K. & Liu, S. Antioxidant curcumin induces oxidative stress to kill tumor cells (Review). Oncol. Lett. 20231220th ed. 27 (2), 67 (2024).","journal-title":"Oncol. Lett."},{"issue":"2","key":"60753_CR79","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.phymed.2012.09.018","volume":"20","author":"M Deters","year":"2013","unstructured":"Deters, M., H\u00fctten, H. & Kaever, V. Synergistic immunosuppressive effects of the mTOR inhibitor sirolimus and the phytochemical curcumin. Phytomedicine 20 (2), 120\u2013123 (2013). 20121015th ed.","journal-title":"Phytomedicine"},{"key":"60753_CR80","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3389\/fonc.2013.00137","volume":"3","author":"F Milano","year":"2013","unstructured":"Milano, F. et al. Nano-curcumin inhibits proliferation of esophageal adenocarcinoma cells and enhances the T cell mediated immune response. Front. Oncol. 20130529th ed. 3, 137 (2013).","journal-title":"Front. Oncol."},{"issue":"1","key":"60753_CR81","first-page":"121","volume":"38","author":"GT Bolger","year":"2018","unstructured":"Bolger, G. T. et al. Distribution of Curcumin and THC in Peripheral Blood Mononuclear Cells Isolated from Healthy Individuals and Patients with Chronic Lymphocytic Leukemia. Anticancer Res. 38 (1), 121\u2013130 (2018).","journal-title":"Anticancer Res."},{"issue":"1","key":"60753_CR82","doi-asserted-by":"publisher","first-page":"7687","DOI":"10.1038\/s41598-022-11364-9","volume":"12","author":"E Duthoo","year":"2022","unstructured":"Duthoo, E., Vral, A. & Baeyens, A. An updated view into the cell cycle kinetics of human T lymphocytes and the impact of irradiation. Sci. Rep. 12 (1), 7687 (2022). 20220510th ed.","journal-title":"Sci. Rep."},{"issue":"4","key":"60753_CR83","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.immuni.2019.03.024","volume":"50","author":"E Batlle","year":"2019","unstructured":"Batlle, E. & Massagu\u00e9, J. Transforming Growth Factor-\u03b2 Signaling in Immunity and Cancer. Immunity 50 (4), 924\u2013940 (2019).","journal-title":"Immunity"},{"issue":"6","key":"60753_CR84","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1002\/biof.1776","volume":"47","author":"X Fu","year":"2021","unstructured":"Fu, X., He, Y., Li, M., Huang, Z. & Najafi, M. Targeting of the tumor microenvironment by curcumin. Biofactors 47 (6), 914\u2013932 (2021).","journal-title":"Biofactors"},{"issue":"3","key":"60753_CR85","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.intimp.2010.08.014","volume":"11","author":"RM Srivastava","year":"2011","unstructured":"Srivastava, R. M., Singh, S., Dubey, S. K., Misra, K. & Khar, A. Immunomodulatory and therapeutic activity of curcumin. Int. Immunopharmacol. 11 (3), 331\u2013341 (2011).","journal-title":"Int. Immunopharmacol."},{"issue":"9","key":"60753_CR86","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.tcb.2020.06.003","volume":"30","author":"MS Paul","year":"2020","unstructured":"Paul, M. S. & Ohashi, P. S. The roles of CD8\u2009+\u2009T cell subsets in antitumor immunity. Trends Cell. Biol. 30 (9), 695\u2013704 (2020).","journal-title":"Trends Cell. Biol."},{"issue":"4","key":"60753_CR87","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1158\/1055-9965.EPI-16-0641","volume":"26","author":"AE Prizment","year":"2017","unstructured":"Prizment, A. E. et al. Cytotoxic T cells and granzyme B associated with improved colorectal cancer survival in a prospective cohort of older women. Cancer Epidemiol. Biomarkers Prev. 26 (4), 622\u2013631 (2017).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"4","key":"60753_CR88","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/cmi.2010.11","volume":"7","author":"S Bhattacharyya","year":"2010","unstructured":"Bhattacharyya, S. et al. Curcumin reverses T cell-mediated adaptive immune dysfunctions in tumor-bearing hosts. Cell. Mol. Immunol. 7 (4), 306\u2013315 (2010). 20100322nd ed.","journal-title":"Cell. Mol. Immunol."},{"issue":"4","key":"60753_CR89","first-page":"1866","volume":"9","author":"B Xu","year":"2017","unstructured":"Xu, B., Yu, L. & Zhao, L. Z. Curcumin up regulates T helper 1 cells in patients with colon cancer. Am. J. Transl Res. 9 (4), 1866\u20131875 (2017). 20170415th ed.","journal-title":"Am. J. Transl Res."},{"issue":"1","key":"60753_CR90","doi-asserted-by":"publisher","first-page":"20770","DOI":"10.1038\/s41598-023-48073-w","volume":"13","author":"E Jalilian","year":"2023","unstructured":"Jalilian, E. et al. Neutralizing tumor-related inflammation and reprogramming of cancer-associated fibroblasts by Curcumin in breast cancer therapy. Sci. Rep. 13 (1), 20770. Available from: https:\/\/doi.org\/10.1038\/s41598-023-48073-w (2023).","journal-title":"Sci. Rep."},{"issue":"1","key":"60753_CR91","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13045-024-01528-7","volume":"17","author":"M Wang","year":"2024","unstructured":"Wang, M., Chen, S., He, X., Yuan, Y. & Wei, X. Targeting inflammation as cancer therapy. J. Hematol. Oncol. 17 (1), 13. Available from: https:\/\/doi.org\/10.1186\/s13045-024-01528-7 (2024).","journal-title":"J. Hematol. Oncol."},{"issue":"2","key":"60753_CR92","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1080\/10408398.2017.1366892","volume":"59","author":"M Saberi-Karimian","year":"2019","unstructured":"Saberi-Karimian, M. et al. Vascular endothelial growth factor: An important molecular target of curcumin. Crit. Rev. Food Sci. Nutr. 59 (2), 299\u2013312 (2019).","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"60753_CR93","doi-asserted-by":"publisher","first-page":"16018","DOI":"10.1038\/mto.2016.18","volume":"3","author":"D Jiao","year":"2016","unstructured":"Jiao, D. et al. Curcumin inhibited HGF-induced EMT and angiogenesis through regulating c-Met dependent PI3K\/Akt\/mTOR signaling pathways in lung cancer. Mol. Ther. Oncolytics. 3, 16018 (2016). 20160803rd ed.","journal-title":"Mol. Ther. Oncolytics"},{"issue":"23","key":"60753_CR94","doi-asserted-by":"publisher","first-page":"19469","DOI":"10.18632\/oncotarget.3625","volume":"6","author":"Z Fu","year":"2015","unstructured":"Fu, Z. et al. Curcumin inhibits angiogenesis and improves defective hematopoiesis induced by tumor-derived VEGF in tumor model through modulating VEGF-VEGFR2 signaling pathway. Oncotarget 6 (23), 19469\u201319482 (2015).","journal-title":"Oncotarget"},{"key":"60753_CR95","doi-asserted-by":"crossref","unstructured":"Brodin BA, Saladino GM, Hertz HM, Arsenian-Henriksson M, Toprak MS. Innate immuno-response to nanoparticle uptake in liver and spleen mimics pathogen infection. Nanomedicine. 2025;20(22).","DOI":"10.1080\/17435889.2025.2571024"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60753-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60753-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60753-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:03:13Z","timestamp":1791205393000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60753-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,5]]},"references-count":95,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["60753"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-60753-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,5]]},"assertion":[{"value":"29 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethical committee of the Kerman University of Medical Sciences with the reference number IR.KMU.AH.REC.1402.009.","order":2,"name":"Ethics","label":"Ethical statement","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"30830"}}